WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Exhibition featuring marine civilization of South China Sea held at Hainan MuseumChinese President Appoints New AmbassadorsScenery of Great Wall in BeijingBreathtaking view of oldest palace in Tibet 'Yumbu Lakhang'E China's Jinzhai County promotes industrial integration, agroView of Bayi Village in China's ChongqingView of tea garden in China's HubeiBeijing launches 22 tourist routes for ice and snow activitiesIn pics: Guangyang Isle in SW China's ChongqingSceneries of Hutuo River after ecological restoration in Shijiazhuang, N China